Lack of CE imports means operations may come to a halt ’22e-’24e EBIT lowered by 68-95% Fair value r...
Demand is holding up well initially in Q2 Small negative adjustments for ’22e-’23e Share of recruitm...
Redeye returns with a second comment following I-Tech’s Q1’22 report.
Zwipe har ingått viktiga samarbetsavtal och erhållit ett Letter of Approval av korttillverkaren Visa...
Redeye thinks Westpay’s Q1 report was slightly better than expected.
Redeye’s comments on the Q1 report that was published earlier this morning.
Normalised revenues EUR 19.1m, 27% growth y-o-y Sales and EBITDA in line with Factset cons.
NoHo Partners reported Q1 EBIT of EUR -1.3m, +51% (EUR 1.
Redeyes view on the Q1 report. With a report slightly above our estimates, we only make minor adjust...
Med Q1-rapporten presenterad står det klart att Obducat inleder 2022 starkt med rapporterade intäkte...
Positive occupancy and NOI margin trend Balance sheet supports further growth New fair value range ...
Mentices VD Göran Malmberg intervjuas av aktieanalytiker Rikard Engberg på Erik Penser Bank.
Learning to Sleep kommunicerade idag den 9 maj 2022 att bolaget förvärvar Symbio Me AB, som är ett d...
AcuCorts användarvänliga kortisonfilm ISICORT® har tidigare erhållit godkännande från Läkemedelsverk...
Still looking for growth but signs are promising Feels like we have been one quarter too early New f...
I dag offentliggjorde Spotlight Group sin delårsrapport för det första kvartalet 2022.
Redeye retains its positive view on Transtema following a Q1 report with underlying sales and EBITA ...
Acquires a leading digital workplace health platform Adding (at least) 3.
Trianon reported solid Q1 2022 numbers, with adjusted EPS growth of 42% y/y, EPRA NAV up 35% y/y, ea...
Based on segment reporting, Taaleri reported Q1 sales of EUR 7.
